[MiR-744-5p inhibits the proliferation, invasion, and migration of clear-cell renal cell carcinoma cells by targeting CCND1]. [PDF]
Lei K, Xie W, Sun T, Liu Y, Wang X.
europepmc +1 more source
【目的】 探讨保留肾单位的手术治疗早期肾癌的效果。【方法】 采用保留肾单位手术治疗肾癌29例,其中双侧肾癌3例,孤立肾肾癌2例, 单侧肾癌24例,其中对侧肾功能存在损害者14例,对侧肾功能正常者10例。【结果】 术后均未发生严重并发症,术后病理均为T1期,其中透明细胞癌21例, 乳头状肾癌5例, 囊性肾癌2例,嫌色细胞癌1例。术后平均随访49.8个月,肿瘤复发2例,复发率为6.9 %。1年、3年、5年无瘤生存率分别为100%、93.1%(27例)、82.8%(24例 ...
doaj
[Therapeutic mechanism of natural astaxanthin against renal clear cell carcinoma based on network pharmacology and bioinformatics]. [PDF]
Gao J, Yang D, Cao R, Pan X, Xia J.
europepmc +1 more source
目的 探讨过氧化物酶体增殖物激活受体γ共激活剂1 α(PGC-1α)在透明细胞型肾细胞癌(ccRCC)中的调控作用。方法 本研究收集在郑州大学附属第一医院治疗的98例ccRCC患者的肾癌和癌旁组织,以及患者一般临床资料。利用RT-qPCR法检测不同临床分期和病理分级ccRCC患者组织中PGC1α mRNA的相对表达水平。使用细胞培养模型786-O、ACHN、RCC4等ccRCC细胞系以及人肾皮质近曲小管上皮永生化细胞系(HK-2)探讨PGC-1α在肿瘤细胞中的作用。采用CCK8实验、细胞克隆形成实验 ...
南永浩 +4 more
doaj
Overexpression of CHMP2B suppresses proliferation of renal clear cell carcinoma cells. [PDF]
Chen X, Wei Q, Zhang Z, Yuan J, Song W.
europepmc +1 more source
[Quercetin inhibits proliferation and migration of clear cell renal cell carcinoma cells by regulating <i>TP53</i> gene]. [PDF]
Gao J, Ye K, Wu J.
europepmc +1 more source
[Clinicopathological and prognostic differences between clear cell and non-clear cell renal cell carcinoma with venous tumor thrombus]. [PDF]
Guo B +8 more
europepmc +1 more source
[Correlations of immune cell infiltration characteristics with clinicopathological parameters in patients with clear cell renal cell carcinoma]. [PDF]
Zhao H +6 more
europepmc +1 more source
[Holliday junction-recognizing protein is a potential predictive and prognostic biomarker for kidney renal clear cell carcinoma]. [PDF]
Zhang H, Ta Q, Feng Y, Han J.
europepmc +1 more source
Constructing a PANoptosis-based prognostic signature to evaluate the immune landscape and therapeutic response in clear cell renal cell carcinoma. [PDF]
Dong Y +12 more
europepmc +1 more source

